Depósito Digital de Documentos de la UAB Encontrados 2 registros  La búsqueda tardó 0.01 segundos. 
1.
8 p, 117.4 KB The Challenges and Opportunities of Pharmacoepidemiology in Bone Diseases / Alarkawi, Dunia (University of New South Wales) ; Ali, M. Sanni (University of Oxford) ; Bliuc, Dana (University of New South Wales) ; Center, Jacqueline R. (St Vincent's Hospital (Sydney)) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
Pharmacoepidemiology is used extensively in osteoporosis research and involves the study of the use and effects of drugs in large numbers of people. Randomized controlled trials are considered the gold standard in assessing treatment efficacy and safety. [...]
2018 - 10.1002/jbm4.10051
JBMR Plus, Vol. 2 (april 2018) , p. 187-194  
2.
9 p, 1.2 MB Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone / Westhrin, Marita (Norwegian University of Science and Technology) ; Holien, Toril (St Olav's University Hospital) ; Zahoor, Muhammad (Norwegian University of Science and Technology) ; Moen, Siv Helen (Norwegian University of Science and Technology) ; Buene, Glenn (Norwegian University of Science and Technology) ; Størdal, Berit (Norwegian University of Science and Technology) ; Hella, Hanne (Norwegian University of Science and Technology) ; Yuan, Huipin (Kuros Biosciences) ; de Bruijn, Joost D. (Queen Mary University of London) ; Martens, Anton (University Medical Center. Cancer Center Amsterdam) ; Groen, Richard W. J. (University Medical Center. Cancer Center Amsterdam) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Smith, Ulf (Sahlgrenska University Hospital (Suècia)) ; Sponaas, Anne-Marit (Norwegian University of Science and Technology) ; Sundan, Anders (Norwegian University of Science and Technology) ; Standal, Therese (St Olav's University Hospital)
Multiple myeloma is characterized by accumulation of malignant plasma cells in the bone marrow. Most patients suffer from an osteolytic bone disease, caused by increased bone degradation and reduced bone formation. [...]
2019 - 10.1002/jbm4.10247
JBMR Plus, Vol. 4 (november 2019)  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.